Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-08

Clinical Trial Update: Bioequivalence Study - Reference Clinical Fexinidazole Tablet Versus Proposed Market Formulation [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated bioequivalence between a reference fexinidazole tablet and the proposed market formulation for African trypanosomiasis; the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fexinidazole (fexinidazole)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Trypanosomiasis, African | Phase 1 | Status: COMPLETED